Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer

NCT00006230 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

NETWORK

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: rubitecan

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC